May 30, 2025 — BiVACOR, a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), announced that its device has received Breakthrough Device ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
-
-
Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw fewer referrals to cardiology, and were prescribed less frequent post-stroke cardiac ...
-
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk ...
-
July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient ...
June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...
June 25, 2025
June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial ...
June 04, 2025
May 30, 2025 — BiVACOR, a clinical-stage medical device company developing the world’s first titanium Total Artificial ...
May 30, 2025Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
April 17, 2025 — Adults younger than 50 years of age had more than double the risk of having a stroke from migraine or ...
April 17, 2025
March 17, 2025 — Bayer recently announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental new ...
March 21, 2025
March 25, 2025 — Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive ...
March 25, 2025
Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw ...
February 07, 2025
Jan. 7, 2025 — FIRE1 recently announced it has received Breakthrough Device Designation from the U.S. Food and Drug ...
January 07, 2025
Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are ...
October 02, 2024
Sept. 30, 2024 — Cytokinetics, Inc. recently announced that additional analyses synthesizing data from SEQUOIA-HCM (Safe ...
October 02, 2024
Sept. 18, 2024 – Astellas Pharma Inc. recently announced that Digitiva, a non-invasive digital health solution for heart ...
September 19, 2024
Aug. 21, 2024 — The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates ...
August 21, 2024
July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & ...
July 31, 2024
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...
July 30, 2024
July 30, 2024 — Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of ...
July 30, 2024